These findings suggest that UCP2 deficiency enhances NLRP3 inflammasome activation and ROS production in neurons in the context of hyperglycemia-exacerbated cerebral I/R damage in vivo and in vitro. Here, NLRP3 is linked to Hyperglycemia.